News
In a new study, researchers looked to better understand and evaluate the range of systemic lupus erythematosus (SLE) symptoms and manifestations by developing the Type 2 Physician Global Assessment ...
A new study suggests preload deficiency could be the underlying cause of fatigue and exercise intolerance in people with systemic lupus erythematosus (SLE).
Systemic lupus erythematosus (SLE) is an autoimmune disease, in which the immune system that normally protects the body from invading microbes turns against the body's own cells. Researchers ...
12d
TipRanks on MSNBiogen’s Litifilimab Study: A Long-Term Look at Lupus Treatment
Biogen (($CC:HTER)) announced an update on their ongoing clinical study. Biogen Inc. (BIIB) is conducting a Phase 3 ...
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is conducting a clinical study titled SELECT-SLE ...
However, for the vast majority of lupus flares the initial treatment has to be systemic glucocorticoids. For most manifestations, prednisone at 0.25–0.5 mg/kg body weight (or equivalent) is ...
9d
News Medical on MSNUniversity of Houston professor creates new drug delivery system to tackle lupus
With a $1 million Impact Award from the U.S. Department of Defense, Tianfu Wu, a University of Houston biomedical engineer, ...
Ianalumab has a dual mechanism of action, B-cell depletion and BAFF-R inhibition, and is being investigated across various B ...
Roivant Sciences said on Monday its experimental drug to treat autoimmune disease systemic lupus erythematosus (SLE) failed to meet the main goal of reducing symptoms in a mid-stage study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results